Preliminary testing of a prespecified liability architecture for autism: theory-guided pathogenetic triad models outperform strength-matched alternatives
By
Darko Sarovic
July 6, 2026
Clinical Scorecard: Initial evaluation of a defined liability framework for autism: theory-driven pathogenetic triad models demonstrate superiority over comparable alternatives
At a Glance
Category Detail
Condition Autism Spectrum Disorder Key Mechanisms Pathogenetic Triad (AP, CC, NB) linking autistic traits, cognitive capacity, and neuropathological burden. Target Population Individuals with autism spectrum disorder. Care Setting Neuropsychiatric evaluation and research.
Key Highlights
The Pathogenetic Triad framework provides a multilevel approach to understanding autism liability. Models incorporating all three PT domains showed systematic advantages over alternative models. The study utilized a case-comparison cohort with dense multimodal characterization. Guideline-Based Recommendations
Diagnosis
Utilize the Autism-Spectrum Quotient for indexing autistic personality. Management
Consider cognitive capacity and neuropathological burden in treatment planning. Monitoring & Follow-up
Assess heart-rate variability as a proxy for neuropathological burden. Risks
Recognize the heterogeneity of autism presentations in clinical assessments. Patient & Prescribing Data
Individuals diagnosed with autism spectrum disorder.
Multimodal approaches may enhance understanding and management of autism.
Clinical Best Practices
Implement theory-guided predictive testing in neurodevelopmental assessments. Utilize a multilevel framework to improve interpretability and clinical relevance of predictive models. Related Resources & Content
